News: SSRIs treat PMS/premenstrual dysphoric disorder

Article

SSRIs effectively treat premenstrual symptoms.

Selective serotonin reuptake inhibitors (SSRIs) (i.e., citalopram, fluoxetine, paroxetine, and sertraline) effectively treat premenstrual symptoms, particularly with continuous dosing, but perhaps not as effectively as previously reported, according to the findings of a recent meta-analysis.

Researchers included 29 published double-blind, randomized controlled studies involving almost 3,000 women in their analysis.

Overall, they found SSRIs significantly effective for treating both PMS and premenstrual dysphoric disorder (OR, 0.40; 95% CI, 0.31–0.51). While no particular SSRI was more effective than another, continuous dosing regimens were more effective (OR, 0.28; 95% CI, 0.18–0.42) than intermittent ones (OR, 0.55; 95% CI, 0.45–0.68).

Shah NR, Jones JB, Aperi J, et al. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol. 2008;111:1175-1182.

Recent Videos
Devon Ramaeker, MD
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Doula highlights how postpartum care is failing new mothers | Image Credit: linkedin.com
Nicky Herrick MD; and Anushree Agarwal, MD, MBBS, highlight their study on cardiac arrhythmias in pregnancy | Image Credit: © Igor Borodin - stock.adobe.com.
Lisa Becht, MD, FACOG, sheds light on fertility awareness | Image Credit: havingbabies.com.
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.